Lead sponsor
TrueBinding, Inc.
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
321
Total enrollment
20
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 1/2
1
Phase 2
1
Not applicable
1
Trials by status
Completed
2
Terminated
1
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's DiseaseAlzheimer's diseasePh 1/2Completed154
A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's DiseaseAlzheimer's diseasePh 2Terminated119